Research Indicates Bedaquiline-Based Regimens For Treating Patients With Multidrug-Resistant Tuberculosis May Be Associated With Favorable Outcomes Compared To Delamanid-Based Regimens
December 10, 2019
Healio (12/9, Stulpin) reports, “Bedaquiline-based regimens for treating patients with multidrug-resistant tuberculosis, MDR-TB, were associated with favorable outcomes and a lower rate of acquired drug resistance compared with delamanid-based regimens, a...